How Often Do You Need CT Scans and Breathing Tests for ILD?
At a Glance
There is no fixed CT schedule for interstitial lung disease. Doctors often use breathing tests more regularly, while repeat high-resolution CT is based on symptoms, lung-function trends, treatment changes, and specific clinical questions because CT uses radiation.
Monitoring Interstitial Lung Disease (ILD) requires a regular schedule of breathing tests and imaging to track whether the disease is stable or progressing. However, there is no one-size-fits-all schedule [1].
Testing is often more frequent (such as every 3 to 6 months) soon after diagnosis, during active disease, or when starting a new treatment. For stable patients, monitoring may happen less often. Your care team will personalize your schedule based on your specific type of ILD, your symptoms, and how your lungs are functioning over time.
Why We Monitor ILD
ILD encompasses many different conditions with different disease courses. While some people remain stable for long periods, others may experience progression that reduces lung function [2]. Because structural changes in your lungs can happen before you notice a difference in how you feel, objective measurements are critical. Routine monitoring helps your doctor determine if your current treatment is working or if your care plan needs adjusting [3].
Breathing Tests (PFTs): Your Main Tracking Tool
Your doctor will rely heavily on Pulmonary Function Tests (PFTs) to track the health of your lungs. Because these tests are safe and do not involve radiation, they are the preferred way to track your condition frequently.
Two key numbers your doctor will watch are:
- Forced Vital Capacity (FVC): This measures the total amount of air you can exhale forcefully after taking a deep breath. A confirmed drop in your FVC over time can be a warning sign of disease progression [4].
- Diffusing Capacity for Carbon Monoxide (DLCO): This uses a safe test gas to estimate how well oxygen passes from your lungs into your blood. Lower DLCO values can also indicate progression [5].
Understanding Your Results: One lower-than-normal reading does not automatically mean your disease is worsening. Test results can be affected by your effort that day, a recent illness, or other factors. Your care team will look at trends over multiple tests, combined with how you are feeling, before making treatment decisions.
CT Scans (HRCT): Detailed Imaging
A High-Resolution Computed Tomography (HRCT) scan provides detailed cross-sectional X-ray images of your lungs. It is highly sensitive for showing the patterns and extent of scarring (fibrosis) or other structural abnormalities [3].
However, because CT scans involve ionizing radiation, doctors weigh the benefit of the information against the radiation exposure. There is no universal rule requiring an annual HRCT scan for every ILD patient [1]. While a 12-month interval is sometimes used in research or for high-risk patients [6], your doctor may only recommend a repeat scan to answer a specific clinical question, such as:
- You have high-risk features associated with an underlying autoimmune disease [7].
- Your PFT numbers show a meaningful, confirmed decline.
- You experience a significant worsening of symptoms [8].
Oxygen and Exercise Testing
Your care team won’t just look at scans and breathing tests; they will also monitor your oxygen levels. You might have normal oxygen levels while resting but experience exertional desaturation (a drop in blood oxygen) when moving [9].
To safely check for this, your doctor may have you perform a clinically supervised 6-minute walk test. This test involves walking at your own pace while your heart rate and oxygen levels are monitored by a professional, providing an objective measure of your exercise capacity [10].
Note on home oximeters: If you use a pulse oximeter at home, remember that readings can be affected by cold fingers, poor circulation, nail polish, and darker skin tones. Always follow your care team’s specific action plan if you get an unexpected reading.
When to Seek Immediate Help
You do not need to wait for your next scheduled test if you feel worse. An acute exacerbation is a sudden, serious worsening of your ILD that requires prompt medical evaluation, not just waiting for a routine scan [11].
Seek emergency medical care (call 911 or go to the nearest emergency room) if you experience:
- Severe breathlessness at rest
- Inability to speak in full sentences
- Chest pain
- Fainting or confusion
- Blue lips or fingertips
- Markedly low oxygen levels that do not improve with your prescribed resting oxygen settings
Common questions in this guide
How often are CT scans usually repeated for interstitial lung disease?
Are breathing tests done more often than CT scans for ILD?
Why might my doctor order another high-resolution CT scan for ILD?
Does one abnormal breathing test mean that my ILD is getting worse?
When should I seek urgent help instead of waiting for my next ILD test?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific schedule of PFTs do you recommend for my stage and type of ILD?
- 2.If my breathing feels worse between scheduled appointments, should I call to move up my testing?
- 3.When considering a repeat HRCT scan, what specific information are we looking for, and does it outweigh the radiation exposure?
- 4.What is my personal oxygen target, and what specific action plan should I follow if my home readings drop below it?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Guiding ILD management in systemic autoimmune rheumatic diseases.
Luppi F, Sebastiani M
Nature reviews. Rheumatology 2024; (20(11)):669-670 doi:10.1038/s41584-024-01160-2.
PMID: 39232244 - 2
Interstitial Lung Disease: A Review.
Maher TM
JAMA 2024; (331(19)):1655-1665 doi:10.1001/jama.2024.3669.
PMID: 38648021 - 3
Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.
Khanna D, Distler O, Cottin V, et al.
Journal of scleroderma and related disorders 2022; (7(3)):168-178 doi:10.1177/23971983211064463.
PMID: 36211204 - 4
Heterogeneity of Rheumatoid Arthritis-Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes.
England BR, Yang Y, Roul P, et al.
Arthritis care & research 2026; (78(2)):249-258 doi:10.1002/acr.25620.
PMID: 40771150 - 5
Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Qiu M, Jiang J, Nian X, et al.
Respiratory research 2021; (22(1)):264 doi:10.1186/s12931-021-01856-z.
PMID: 34635095 - 6
Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment.
Kim HJ, Tashkin DP, Gjertson DW, et al.
Annals of the rheumatic diseases 2016; (75(7)):1367-71 doi:10.1136/annrheumdis-2015-208929.
PMID: 26757749 - 7
Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines Into Clinical Practice.
Esposito AJ, Selvan KC, Richardson C, et al.
Chest 2025; doi:10.1016/j.chest.2025.11.047.
PMID: 41397518 - 8
Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis.
Spagnolo P, Wuyts W
Current opinion in pulmonary medicine 2017; (23(5)):411-417 doi:10.1097/MCP.0000000000000405.
PMID: 28582317 - 9
The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung disease.
Oishi K, Matsunaga K, Asami-Noyama M, et al.
NPJ primary care respiratory medicine 2022; (32(1)):5 doi:10.1038/s41533-022-00268-w.
PMID: 35087054 - 10
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
Waxman A, Restrepo-Jaramillo R, Thenappan T, et al.
The New England journal of medicine 2021; (384(4)):325-334 doi:10.1056/NEJMoa2008470.
PMID: 33440084 - 11
Acute Onset Anti-Synthetase Syndrome With Pericardial Effusion and Non-Specific Interstitial Pneumonia.
Shah A, Patel SR
Journal of clinical medicine research 2016; (8(9)):683-7 doi:10.14740/jocmr2631w.
PMID: 27540445
This page is for informational purposes only and does not constitute medical advice. Your ILD care team should set your testing schedule and interpret changes in your symptoms, breathing tests, oxygen levels, or CT scans.
Get notified when new evidence is published on Interstitial lung disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.